Partners L P/il Bvf's Net Worth
Estimate Recalculated Jul 2, 2025 11:05PM EST
Who is Partners L P/il Bvf
Partners L P/il Bvf has an estimated net worth of $1.44 Billion. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Therapeutics Inc., ARENA PHARMACEUTICALS INC, IMMUNE DESIGN CORP., Oncothyreon Inc., ORTHOLOGIC CORP, ChemoCentryx, Inc., DYNAVAX TECHNOLOGIES CORP, REPLIGEN CORP, KENT INTERNATIONAL HOLDINGS INC, NEUROCRINE BIOSCIENCES INC, XOMA Corp, LIGAND PHARMACEUTICALS INC, RIGEL PHARMACEUTICALS INC, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., CURIS INC, Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., PALATIN TECHNOLOGIES INC, MEDICINOVA INC, TARGACEPT INC, CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ADVANCED MAGNETICS INC, ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., NPS PHARMACEUTICALS INC, ICAGEN INC, ADOLOR CORP, Third Harmonic Bio, Inc., ZONAGEN INC, COMBINATORX, INC, Regado Biosciences Inc, SUPERGEN INC, FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARRAY BIOPHARMA INC, ARQULE INC, AEOLUS PHARMACEUTICALS, INC., INHIBITEX, INC., NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, enGene Holdings Inc., Celera CORP, FACET BIOTECH CORP, PHARMACOPEIA INC, AVIGEN INC \DE, SGX PHARMACEUTICALS, INC., VIACELL INC, NEUROGEN CORP, POINT Biopharma Global Inc., GENAERA CORP, AEROGEN INC, CORVAS INTERNATIONAL INC, BIOCRYST PHARMACEUTICALS INC, and APPLIED MOLECULAR EVOLUTION INC.
SEC CIK
Partners L P/il Bvf's CIK is 0001055947
Past Insider Trading and Trends
2020 was Partners L P/il Bvf's most active year for acquiring shares with 117 total transactions. Partners L P/il Bvf's most active month to acquire stocks was the month of April. 2009 was Partners L P/il Bvf's most active year for disposing of shares, totalling 80 transactions. Partners L P/il Bvf's most active month to dispose stocks was the month of March. 2021 saw Partners L P/il Bvf paying a total of $132,144,944.64 for 12,200,650 shares, this is the most they've acquired in one year. In 2023 Partners L P/il Bvf cashed out on 38,262,305 shares for a total of $279,968,464.50, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
